Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03178552
Title A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) (B-FAST)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

lung squamous cell carcinoma

lung non-small cell carcinoma

Therapies

Entrectinib

Carboplatin + Cisplatin + Gemcitabine

Atezolizumab

Carboplatin + Cisplatin + Pemetrexed Disodium

Atezolizumab + Cobimetinib + Vemurafenib

Alectinib

Age Groups: senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST